Answers are grounded in this paper and cite their sources.
New taxonomy evaluates broader value elements of mRNA vaccines for national funding decisions, indicating comprehensive valuations.
Many value elements in the taxonomy are traditional narrow values and fit within a health payer perspective, but the taxonomy also captures broader societal values. This taxonomy can support more comprehensive valuations of mRNA combo vaccines in national vaccine recommendation and funding decisions.
No takes yet. Share an insight, caveat, or question.
Sevilla et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: